About
Immuno-oncology, Oncolytic Virus
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirus TechnologyNorway
Team (2)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
42,123
By Phase
NA: 1
By Status
RECRUITING: 1COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06354192Lead Sponsor
Precision Nudging for Hypertension Management: Observational Study
N/ARecruiting
12,000 participants
Started: May 1, 2024 · Completed: Nov 1, 2026
NCT05509049Lead Sponsor
Precision Nudging Drives Wellness Visit Attendance at Scale
NACompleted
30,068 participants
Started: Sep 7, 2022 · Completed: Jan 9, 2024
NCT04990635Collaborator
Evaluation of Caudal Block Success With Perfusion Index
N/AUnknown
55 participants
Started: Aug 17, 2021 · Completed: Sep 30, 2021
Locations (1)
Headquarters
Oslo, Norway
Map
Loading map...